IE790954L - Pharmaceutical formulations containing prostaglandin¹compounds - Google Patents
Pharmaceutical formulations containing prostaglandin¹compoundsInfo
- Publication number
- IE790954L IE790954L IE790954A IE95479A IE790954L IE 790954 L IE790954 L IE 790954L IE 790954 A IE790954 A IE 790954A IE 95479 A IE95479 A IE 95479A IE 790954 L IE790954 L IE 790954L
- Authority
- IE
- Ireland
- Prior art keywords
- pharmaceutical formulations
- formulations containing
- prostacyclin
- gb2021581a
- dimethylprostacyclin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Stabilised pharmaceutical formulations of prostacyclin, 15- methyl-prostacyclin or 16,16- dimethylprostacyclin are prepared by addition of a buffer comprising an amino acid (preferably glycine) as the principal buffering agent.
[GB2021581A]
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2017578 | 1978-05-17 | ||
GB7917158A GB2021581B (en) | 1978-05-17 | 1979-05-17 | Stabilisation of pgl derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
IE790954L true IE790954L (en) | 1980-11-17 |
IE48231B1 IE48231B1 (en) | 1984-11-14 |
Family
ID=26254508
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE954/79A IE48231B1 (en) | 1978-05-17 | 1979-08-08 | Pharmaceutical formulations containing prostaglandin compounds |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB2021581B (en) |
IE (1) | IE48231B1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3010002A1 (en) * | 1980-03-15 | 1981-10-01 | Hoechst Ag, 6000 Frankfurt | PROSTAGLANDINE CONTAINING PHARMACEUTICAL PREPARATION |
FR2740686B1 (en) | 1995-11-03 | 1998-01-16 | Sanofi Sa | STABLE LYOPHILIZED PHARMACEUTICAL FORMULATION |
CA2868998A1 (en) | 2006-02-03 | 2007-08-16 | Actelion Pharmaceuticals Ltd. | Novel epoprostenol formulation and method of making thereof |
-
1979
- 1979-05-17 GB GB7917158A patent/GB2021581B/en not_active Expired
- 1979-08-08 IE IE954/79A patent/IE48231B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB2021581B (en) | 1982-10-20 |
GB2021581A (en) | 1979-12-05 |
IE48231B1 (en) | 1984-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG18729A (en) | Compound of n- amino - 1,2,4-triazinones used as insecticide. | |
AU530380B2 (en) | Amino acid derivatives as antihypertensives | |
IE790145L (en) | 9-DEOXY-9a-METHYLENE ISOESTERS OF PGI(2) | |
AU596081B2 (en) | Peptide usable as an intermediate for the production of a physiologically active peptide | |
EP0695171A1 (en) | Lyospheres comprising gonadotropin | |
EP0336760A3 (en) | Bone-inducing protein | |
IT8921118A0 (en) | COMPOSITION FOR AEROSOL INCLUDING NITROGLYCERIN AS THE ACTIVE INGREDIENT. | |
AU4936890A (en) | Medicament containing dihydrolipoic acid as active substance | |
IE811650L (en) | Stabilized thieno-pyridine compositions | |
AU525695B2 (en) | Pharmaceutical formulations of prostacyclin | |
IE790954L (en) | Pharmaceutical formulations containing prostaglandin¹compounds | |
AU5342386A (en) | Pesticidal compositions | |
AU4545289A (en) | 2-azabicyclo(2.2.1)hept-5-ene-2-acetic acid, derivatives thereof and related compounds, process for the preparation of said compounds and the use of said compounds for the manufacture of n-phosphonomethylglycine | |
IE811951L (en) | Oxazaphosphorins | |
EP0063328A3 (en) | Compositions containing secretin and method for preventing the adsorption of secretin | |
EP0476156A4 (en) | Solid oral preparation containing catechol compound | |
IE791818L (en) | Endoparasiticidal paste | |
AU2403592A (en) | 2-aza-2-desamino analogues of 5,8-dideazafolic acid | |
AU7927987A (en) | Pharmaceutical peptide compositions, also containing poly-d-3-hydroxybutyric acid and calcium acetate/glycerol adduct | |
AU2130283A (en) | Novel herbicides&n,n-dialkyl-2-(4:-substituted-1:napthoxy) propionamides | |
EP0315916A3 (en) | A novel ether compound, a method for producing it, a composition containing it as an active ingredient and its use | |
IE41017L (en) | Thionophosphoric acid ester | |
ES8304924A1 (en) | Peptide, process for preparation thereof and use thereof. | |
PL276370A1 (en) | Method for preparation of peptides, containing the n3-brom- or n3-iodoacetyl-l-2,3-diaminepropanic acid | |
JPS52148019A (en) | Physiological active amino acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK9A | Patent expired |